BOLDER BIOTECHNOLOGY RECEIVES NIH GRANT

Bolder BioTechnology has been awarded a grant for more than $300,000 from NIH. The grant will be used to develop the company's proprietary long-acting growth hormone product. The product is being analyzed as a potential treatment for growth hormone deficiency, short stature in children and HIV-related wasting.

Denver Business Journal (http://www.bizjournals.com/denver/stories/2005/01/10/daily35.html)